Vireo Growth Finalizes 30-for-1 Reverse Stock Split
Summary
Vireo Growth Inc. announced the completion of a 30-for-1 reverse stock split, effective June 5, 2026, significantly reducing outstanding shares to improve marketability.
Key Events · Corporate Governance and Compliance · VREOF
-
Reverse Stock Split Finalized
Shareholders approved a reverse stock split proposal on May 29, 2026, which the Board finalized at a 30-for-1 ratio on June 1, 2026.
-
Effective Date
The 30-for-1 share consolidation became effective at market open on June 5, 2026.
-
Share Count Reduction
The number of outstanding subordinate voting shares was reduced from approximately 1.45 billion to 48.5 million post-consolidation.
-
New Identifiers
New ISIN and CUSIP numbers have been issued for the post-consolidation shares.
Analysis · VREOF · Life Sciences
Vireo Growth Inc. has finalized the terms of its previously announced reverse stock split. Shareholders approved the proposal on May 29, 2026, and the Board subsequently set the ratio at 30-for-1, effective June 5, 2026. This action significantly reduces the number of outstanding shares, which can improve the per-share price and potentially enhance marketability and eligibility for certain exchange listings. While reverse splits are often viewed with caution, in Vireo's case, it follows a period of strong financial performance and strategic acquisitions, suggesting it is a move to optimize capital structure rather than a sign of distress.
At the time of this filing, VREOF was trading at $0.42 on OTC in the Life Sciences sector, with a market capitalization of approximately $490.8M. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.